Tarlatamab-dlle, 1 mg
IMDELLTRA
1mg
C9170
Immunotherapy
T Cell Receptor (TCR)
DLL3, CD3
No
2024
 
Sept. 11, 2024
Dec. 17, 2024
No Longer Used